Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 14, 2026 | May 15, 2026 |
| WILLIAMS SONOMA INCWSM · Entity 3176 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 18,355.0364 |
Reported balance
After 2026-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 1,544.0041 · Balance 18,355.0364 F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
WILLIAMS SONOMA INC
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,198 |
Ending reported balance
After 2026-06-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-18 · Exercise / conversion · Acquired 162 · Balance 9,770 Row 2 · 2026-06-18 · Exercise / conversion · Acquired 148 · Balance 9,918 Row 3 · 2026-06-18 · Exercise / conversion · Acquired 171 · Balance 10,089 Row 4 · 2026-06-18 · Exercise / conversion · Acquired 109 · Balance 10,198 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,028 |
Reported balance
After 2026-06-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-18 · Grant · Acquired 1,028 · Balance 1,028 F1: Each restricted stock unit represents a contingent right to receive one share of WSM common stock. F2: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-18 · Exercise / conversion · Disposed 162 · Balance 0 F3: Each deferred stock unit represents a contingent right to receive one share of WSM common stock. F4: The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-18 · Exercise / conversion · Disposed 148 · Balance 0 F3: Each deferred stock unit represents a contingent right to receive one share of WSM common stock. F4: The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-18 · Exercise / conversion · Disposed 171 · Balance 0 F3: Each deferred stock unit represents a contingent right to receive one share of WSM common stock. F4: The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-06-18 · Exercise / conversion · Disposed 109 · Balance 0 F3: Each deferred stock unit represents a contingent right to receive one share of WSM common stock. F4: The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of WSM common stock.
F2: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting.
F3: Each deferred stock unit represents a contingent right to receive one share of WSM common stock.
F4: The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 2, 2022 23:24 UTC | WILLIAMS SONOMA INC WSM · Entity 3176 | GrantRestricted Stock Units · Derivative | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016509 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,328 Underlying: Common Stock · 1,328 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of WSM common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:24 UTC | WILLIAMS SONOMA INC WSM · Entity 3176 | Exercise / conversionRestricted Stock Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016509 · form4.xml · derivative · entry 2 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of WSM common stock. F2 · derivative.exercise_date: The restricted stock units fully vested on May 31, 2022. F2 · derivative.expiration_date: The restricted stock units fully vested on May 31, 2022. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:24 UTC | WILLIAMS SONOMA INC WSM · Entity 3176 | Exercise / conversionCommon Stock | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016509 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,384 | $97.99 | $135,618.16 |
DisclosureSEC source: 0001127602-22-014413 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,892.2482 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,314 | $92.73 | $121,847.22 |
DisclosureSEC source: 0001127602-21-029711 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:35 UTC | WILLIAMS SONOMA INC WSM · Entity 3176 | GrantRestricted Stock Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028749 · form4.xml · derivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455 Underlying: Common Stock · 455 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of WSM common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,446 | $84.27 | $121,854.42 |
DisclosureSEC source: 0001127602-21-016902 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,836.85 | $66.35 Strike: $0.00 | $121,875.00 |
DisclosureSEC source: 0001127602-20-029700 · form4.xml · derivative · entry 2 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,959.8195 Underlying: Common Stock · 1,836.85 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,955.9461 | $62.31 Strike: $0.00 | $121,875.00 |
DisclosureSEC source: 0001127602-20-016757 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,991.0705 Underlying: Common Stock · 1,955.9461 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,551 | $74.92 | $116,200.92 |
DisclosureSEC source: 0001127602-19-033583 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,551 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,222 | $52.30 | $116,210.60 |
DisclosureSEC source: 0001127602-19-019167 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,332 | $78.77 | $104,921.64 |
DisclosureSEC source: 0001127602-18-032661 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,332 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,638 | $64.10 | $104,995.80 |
DisclosureSEC source: 0001127602-18-020158 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,521.9597 | $68.99 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-17-031739 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,585.9988 Underlying: Common Stock · 1,521.9597 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. The share credits are scheduled to be settled in common stock in 2022. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,297.2572 | $80.94 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-17-017957 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009.4012 Underlying: Common Stock · 1,297.2572 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,250 | $83.95 | $104,937.50 |
DisclosureSEC source: 0001127602-16-066174 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052958 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| January 04, 2016 Filed Jan 5, 2016 22:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,000 | $95.87 | $191,749.20 |
DisclosureSEC source: 0001127602-16-035910 · form4.xml · nonDerivative · entry 2 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 14,719 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $95.81 and $96.05 per share. Read SEC document |
| November 25, 2015 Filed Jan 5, 2016 22:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 600 | $93.90 | $56,340.00 |
DisclosureSEC source: 0001127602-16-035910 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 16,719 Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,406 | $99.57 | $139,995.42 |
DisclosureSEC source: 0001127602-15-030641 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 07, 2015 Filed May 11, 2015 20:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,409 | $99.36 | $139,998.24 |
DisclosureSEC source: 0001127602-15-016834 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,200 | $87.50 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-14-031477 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,593.5407 Underlying: Common Stock · 1,200 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election Read SEC document |
| May 08, 2014 Filed May 9, 2014 20:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,384.1287 | $75.86 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-14-016996 · form4.xml · derivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384.1287 Underlying: Common Stock · 1,384.1287 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,526 | $63.87 | $97,465.62 |
DisclosureSEC source: 0001127602-13-031084 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,526 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,695 | $57.49 | $97,445.55 |
DisclosureSEC source: 0001127602-13-016472 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 500 | $57.24 | $28,620.00 |
DisclosureSEC source: 0001127602-13-013973 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 11,283 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 08, 2012 Filed Nov 9, 2012 21:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,099 | $46.43 | $97,456.57 |
DisclosureSEC source: 0001127602-12-030334 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| September 17, 2012 Filed Sep 18, 2012 20:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,000 | $46.87 | $46,870.00 |
DisclosureSEC source: 0001127602-12-026553 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 9,684 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 10, 2012 Filed May 14, 2012 20:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,120 | $45.97 | $97,456.40 |
DisclosureSEC source: 0001127602-12-016753 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,684 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 02, 2011 Filed Nov 4, 2011 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,407 | $35.77 | $121,868.39 |
DisclosureSEC source: 0001127602-11-028663 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,564 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 11, 2011 Filed May 13, 2011 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,250 | $37.50 | $121,875.00 |
DisclosureSEC source: 0001127602-11-016258 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,157 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| March 09, 2011 Filed Mar 11, 2011 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,907 | $34.07 | $64,971.49 |
DisclosureSEC source: 0001127602-11-010011 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,907 F1 · shares: Consists of common stock acquired as a prorated portion of the reporting person's 2011 compensation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.